نتایج جستجو برای: moxifloxacin hydrochloride

تعداد نتایج: 46374  

Journal: :The European respiratory journal 2012
Philipp Wassmer Joannis Chronis Jochen J Rüdiger Katia Boggian

the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516–528. 4 Gumbo T, Louie A, Deziel MR, et al. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. J Infect Dis 2004; 190: 1642–1651. 5 Liang H, Kays MB, Sowinski KM. Separatio...

Journal: :American journal of respiratory and critical care medicine 2009
Susan E Dorman John L Johnson Stefan Goldberg Grace Muzanye Nesri Padayatchi Lorna Bozeman Charles M Heilig John Bernardo Shurjeel Choudhri Jacques H Grosset Elizabeth Guy Priya Guyadeen Maria Corazon Leus Gina Maltas Dick Menzies Eric L Nuermberger Margarita Villarino Andrew Vernon Richard E Chaisson

RATIONALE Moxifloxacin has potent activity against Mycobacterium tuberculosis in vitro and in a mouse model of antituberculosis (TB) chemotherapy, but data regarding its activity in humans are limited. OBJECTIVES Our objective was to compare the antimicrobial activity and safety of moxifloxacin versus isoniazid during the first 8 weeks of combination therapy for pulmonary TB. METHODS Adults...

Journal: :The Journal of antimicrobial chemotherapy 2012
Gunther Wiesner Siegmund-Lorenz Braun Michael Gruber Ralph Gertler Rüdiger Lange Peter Tassani Klaus Martin

OBJECTIVES In vitro and experimental studies in animals have established the anti-inflammatory effects of moxifloxacin. Cardiopulmonary bypass (CPB) leads to an inflammatory response. The aim of this study was to assess whether the inflammatory cytokine response to CPB is reduced with a perioperative antibiotic prophylaxis, either moxifloxacin or cefuroxime (the standard prophylaxis). PATIENT...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Banurekha V Velayutham Iliayas S Allaudeen Gomathi N Sivaramakrishnan Venkatesan Perumal Dina Nair Ponnuraja Chinnaiyan Paul K Paramasivam Baskaran Dhanaraj Ramesh K Santhanakrishnan Gangadevi P Navaneethapandian Makesh K Marimuthu Vanaja Kumar Chandrasekaran Kandasamy Kalaiselvi Dharuman Thiruvalluvan Elangovan Meenakshi Narasimhan Sridhar Rathinam Gangadharan Vadivelu Prabhakaran Rathinam Chandrasekar Chockalingam Lavanya Jayabal Soumya Swaminathan Jawahar M Shaheed

BACKGROUND Rapid sputum culture conversion at 2 months indicates the sterilizing capacity and potential of regimens to shorten duration of tuberculosis treatment. We compared results of sputum culture conversion by moxifloxacin and control regimens and identified factors affecting sputum culture positivity after 2 months of treatment. METHODS Human immunodeficiency virus-uninfected adults wit...

Journal: :Annals of the Academy of Medicine, Singapore 2001
M L Ling P L Tan

INTRODUCTION The emergence of resistance to common antimicrobials in bacteria has been increasingly reported in various countries. Empirical antimicrobial therapy of various infections would therefore need to be reviewed. The introduction of new fluoroquinolones has created an interest in the use of these as possible agents in the empirical treatment of respiratory tract infections. MATERIALS...

Journal: :Journal of chromatographic science 2006
S Schulte T Ackermann N Bertram T Sauerbruch W D Paar

A simple, accurate, sensitive, and precise reversed-phase (RP) high-performance liquid chromatographic (HPLC) method with fluorescence detection allowing the sensitive and specific quantitation of the newer fluoroquinolones levofloxacin and moxifloxacin is described. Moxifloxacin is used as the internal standard for the determination of levofloxacin and vice versa. A single-step liquid-liquid e...

Journal: :Archives of ophthalmology 2006
Darlene Miller Patrick M Flynn Ingrid U Scott Eduardo C Alfonso Harry W Flynn

OBJECTIVE To evaluate the in vitro susceptibility and cross-resistance of gatifloxacin and moxifloxacin vs older fluoroquinolones among coagulase-negative staphylococci recovered from patients with clinical endophthalmitis. METHODS A combination of E tests and disk diffusion methods was used to determine in vitro susceptibility and cross-resistance for 111 coagulase-negative staphylococci iso...

2015
Chin Kook Rhee Jung Hyun Chang Eu gene Choi Hyun kuk Kim Yong-Soo Kwon Sun Young Kyung Ji-Hyun Lee Myung Jae Park Kwang Ha Yoo Yeon Mok Oh

A new quinolone, zabofloxacin, has now been developed; hence, a non-inferiority trial is needed to compare this new compound with another widely used quinolone to examine its efficacy and safety for the treatment of chronic obstructive pulmonary disease (COPD) exacerbations. This was a prospective, multicenter, double-blind, double-dummy, randomized, controlled, parallel-group, Phase III, non-i...

Journal: :Surgical infections 2014
Jan J De Waele Jose M Tellado Günter Weiss Jeffrey Alder Frank Kruesmann Pierre Arvis Tajamul Hussain Joseph S Solomkin

BACKGROUND Secondary peritonitis is an advanced form of complicated intra-abdominal infection (cIAI) requiring hospitalization, surgical source control, and empiric antibiotic therapy against causative aerobic and anaerobic bacteria. METHODS This pooled analysis of four prospective, active-controlled randomized clinical trials compared the efficacy and safety of moxifloxacin with that of comp...

Journal: :Reactions Weekly 2021

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید